Rheumatology

Glucagon-like peptide 1 receptor agonist use significantly lowers the long-term risk of total knee arthroplasty in osteoarthritis.

Patients receiving modern B-cell-depleting therapies face a heightened risk of severe arboviral disease with substantial mortality.

Particulate matter exposure significantly increases clinical disease activity and heightens the risk of rheumatoid arthritis flares.

Comprehensive analysis of 29 clinical trials evaluates chimeric antigen receptor cellular therapies for systemic sclerosis patients.

Noncanonical TRF2 activity in muscle stem cells orchestrates skeletal muscle regeneration independently of classical telomere dysfunction.

A landmark multi-cohort study identified 26 candidate genetic risk loci defining fibromyalgia as a central nervous system disorder.

Artificial intelligence in rheumatoid arthritis optimizes early diagnostic detection, image analysis, and targeted drug selection.

New real-world evidence shows that GLP-1 receptor agonists significantly reduce joint pain and inflammation in psoriatic arthritis.